RT Journal Article SR Electronic T1 Active cytomegalovirus retinitis after the start of antiretroviral therapy JF British Journal of Ophthalmology JO Br J Ophthalmol FD BMJ Publishing Group Ltd. SP 157 OP 160 DO 10.1136/bjophthalmol-2018-312406 VO 103 IS 2 A1 David Heiden A1 NiNi Tun A1 Frank N Smithuis A1 Jeremy David Keenan A1 Catherine E Oldenburg A1 Gary N Holland A1 W Lawrence Drew YR 2019 UL http://bjo.bmj.com/content/103/2/157.abstract AB Patients with AIDS-related cytomegalovirus (CMV) retinitis receiving combined antiretroviral therapy (cART), but not specific anti-CMV therapy, consistently showed active retinitis for several months. Delayed diagnosis and treatment of CMV retinitis may have severe consequences. Patients first entering care with advanced HIV infection and vulnerability to reactivation of latent CMV infection should be screened immediately for CMV retinitis by dilated indirect ophthalmoscopy and treated with specific anti-CMV therapy without delay, in addition to cART.